Related Experiment Video

Updated: Jun 28, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.3K

Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel

Hanjie Yang1, Min Li1, Yuhao Deng1

  • 1Department of Pediatric Neurosurgery, Neurosurgery Center, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Genes, Chromosomes & Cancer
|April 12, 2024
PubMed

Insights

Novel treatments targeting the tumor microenvironment (TME) are crucial for refractory medulloblastomas, particularly the SHH and group 3 subgroups. Understanding TME interactions offers promising therapeutic strategies for these aggressive pediatric brain tumors.

Area of Science:

  • Pediatric Oncology
  • Neuro-Oncology
  • Cancer Immunology

Background:

  • Medulloblastomas are the most common malignant pediatric brain tumors, with distinct molecular subgroups.
  • The sonic hedgehog (SHH) subgroup with TP53 mutation and group 3 medulloblastomas exhibit poor prognoses due to high recurrence and metastasis rates.
  • The tumor microenvironment (TME) significantly impacts tumor progression, including immunosuppression, angiogenesis, and inflammation.

Purpose of the Study:

  • To review current research on medulloblastoma microenvironment components and their interactions.
  • To explore the potential of TME-targeting therapies for refractory medulloblastomas.
  • To identify challenges and future directions in TME-based medulloblastoma treatment.

Main Methods:

  • Literature review of studies on medulloblastoma and its tumor microenvironment.
  • Analysis of research on the role of TME components in tumor growth, recurrence, and metastasis.
  • Synthesis of information on emerging TME-targeting therapeutic strategies.

Main Results:

  • The TME plays a critical role in medulloblastoma development and progression.
  • Specific TME components influence immunosuppression, angiogenesis, and inflammation in medulloblastomas.
  • Targeting the TME presents a promising avenue for novel medulloblastoma therapies.

Conclusions:

  • Targeting the tumor microenvironment offers a promising strategy for treating refractory medulloblastomas.
  • Further research is needed to overcome challenges and optimize TME-based therapies.
  • Understanding TME interactions is key to developing effective treatments for high-risk medulloblastoma subgroups.
Keywords:
extracellular matriximmune cellsmedulloblastomatumor microenvironmenttumor‐associated astrocytesvasculature

More Related Videos

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.1K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K